Islet amyliod polypeptide-derived amyloid deposition increases along with the duration of type 2 diabetes mellitus
- 31 January 1992
- journal article
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 15 (1) , 17-21
- https://doi.org/10.1016/0168-8227(92)90062-v
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Fasting Serum Insulin Concentration and Early Insulin Response as Risk Determinants for Developing DiabetesDiabetic Medicine, 1990
- Secretion of islet amyloid polypeptide in response to glucoseFEBS Letters, 1989
- Human Diabetes Associated with a Deletion of the Tyrosine Kinase Domain of the Insulin ReceptorScience, 1989
- The complete islet amyloid polypeptide precursor is encoded by two exonsFEBS Letters, 1989
- Islet amyloid polypeptide inhibits glucose-stimulated insulin secretion from isolated rat pancreatic isletsBiochemical and Biophysical Research Communications, 1989
- The Natural History of Impaired Glucose Tolerance in the Pima IndiansNew England Journal of Medicine, 1988
- Increased Insulin Concentrations in Nondiabetic Offspring of Diabetic ParentsNew England Journal of Medicine, 1988
- Islet amyloid polypeptide: Identification and chromosomal localization of the human geneFEBS Letters, 1988
- Pancreatic amylin and calcitonin gene-related peptide cause resistance to insulin in skeletal muscle in vitroNature, 1988
- The influence of amyloid deposits on the islet volume in maturity onset diabetes mellitusDiabetologia, 1978